SELLAS Life Sciences Group, Inc. — Director's Dealing 2011

Sep 28, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (RXII)
CIK: 0001390478
Period of Report: 2011-09-24

Reporting Person: Pavco Pamela (Former VP Pharma Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-09-24	Stock Option (right to buy)	$0.65	A	150000	Acquired	2021-09-24	Common Stock (150000)	Direct

Footnotes

F1: Granted pursuant to the issuer's 2007 Incentive Plan

F2: The option will vest and become exercisable in three equal installments on the sixth, twelfth, and eighteenth month following April 1, 2011